What’s in Shortage

Clonazepam tablets, also known by the brand name Klonopin, are currently listed on the FDA drug shortage database. This medication is utilized across several therapeutic categories, including Neurology, Pediatrics, and Psychiatry. The shortage was first posted on March 10, 2023, and was most recently updated on February 3, 2026.

Which Manufacturers Are Affected

According to the latest data, the following manufacturers have specific presentations of the drug available, though the medication remains in an overall shortage status:

• Accord Healthcare Inc.

  • Status: Available
  • Presentations:
    • Clonazepam, Tablet, 0.5 mg (NDC 16729-136-00, 16729-136-16)
    • Clonazepam, Tablet, 1 mg (NDC 16729-137-00, 16729-137-16)
    • Clonazepam, Tablet, 2 mg (NDC 16729-138-00, 16729-138-16)
  • Contact: 866-941-7875, option 2

• Cheplapharm Arzneimittel GmbH (Marketed by H2-Pharma)

  • Status: Available
  • Presentations:
    • Klonopin, Tablet, 0.5 mg (NDC 61269-605-10)
    • Klonopin, Tablet, 1 mg (NDC 61269-610-10)
    • Klonopin, Tablet, 2 mg (NDC 61269-620-10)
  • Contact: orders@h2-pharma.com

Why There’s a Shortage

No specific reason for the shortage was provided in the source data at this time.

What Patients Should Do

If you are prescribed Clonazepam and are experiencing difficulty filling your prescription, consider the following steps:

• Speak with your pharmacist: They can check current stock levels or attempt to order from different distributors.
• Consult your healthcare provider: Discuss your treatment plan and any concerns regarding medication access.
• Contact manufacturers: You may use the contact information provided above to inquire about supply availability in your region.

Disclaimer: Patients should always consult with their healthcare provider regarding their medical treatment and any changes to their medication regimen.

Source

Attribution: FDA Drug Shortage Database